Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Oklahoma discovery could restore hearing with a pill

Get in Touch

By Scott Meacham
Copyright © 2017, The Oklahoma Publishing Co.

Does anyone in your life suffer from hearing loss?

In the U.S., hearing loss impacts the daily lives of 48 million people from young to old — in classrooms, in conversation, in business and social settings, even at home as they watch a football game or the news.

Imagine the impact if there was a pill that could prevent hearing loss and regenerate the nerve endings inside the ear to restore hearing to people whose hearing has already declined.

Such a therapy is moving toward clinical testing at Otologic Pharmaceutics, a spinout of technology from the Hough Ear Institute and Oklahoma Medical Research Foundation.

Otologic Pharmaceutics is out to prevent and reverse neural hearing loss. The two biggest causes of this condition (also known as nerve deafness) are aging and noise, which destroy the sensory hair cells and the nerve endings in the ear.

At age 65, about one in three people has a hearing loss, which may not be much of a surprise. However, a recent study by the U.S. Centers for Disease Control states that about 10 percent of the entire millennial generation suffers from hearing loss. This damage may not show up until later, but it’s happening today. The common culprits are everywhere: earbuds, loud music, concerts and TV, leaf blowers and lawn mowers, construction noise, and, for those in the military, explosions.

“We call the pill we are working on the bomb-blast pill,” said Dr. Richard Kopke, CEO of Hough Ear Institute and chief medical officer of Otologics. “In the military, blast injuries, which produce ringing in the ear and sound when there is nothing producing sound, are very common. It was a serendipitous discovery that as we were testing the pill as a therapy to prevent hearing damage, we discovered that it actually regrew the nerve endings that connect the inner ear to the brain, restoring hearing.”

Otologics is also testing its hearing loss prevention therapy in cancer treatments that involve cisplatin, a drug that is effective against multiple types of cancer but causes hearing loss in a significant percentage of patients. About 700,000 people a year are treated with cisplatin.

“We look at the ear and inner ear all day long,” Kopke said. “It takes your breath away, the beauty of the design. I started working in this field in 1996, for the majority of that time, up until about four years ago, I would have said that auditory hair cell regeneration with auditory restoration was impossible. When we saw hair cells coming back and hearing coming back, and we could reproduce it, it was jaw dropping for us.”

It is jaw dropping to think that a technology discovered and commercialized here in Oklahoma has the potential to improve the lives of so many millions of people.

This is what an innovation economy is all about.

Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state support from the Oklahoma Center for the Advancement of Science and Technology and is an integral part of Oklahoma’s Innovation Model. Email Meacham at i2E_Comments@i2E.org.

Read the article at newsok.com

 

 

 

Author

  • Sarah Graves Sarah Graves

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E